Nephron Pharmaceuticals develops and produces safe, affordable generic inhalation solutions and suspension products. The company also operates a 503B Outsourcing Facility that produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals across America. Led by CEO Lou Kennedy, Nephron supplies hospitals and healthcare providers with sterile injectable and inhalation therapies. The company raised $350M in funding and intends to use the proceeds to support future growth. Nephron is based in West Columbia, South Carolina, and focuses on expanding its pharmaceutical manufacturing and outsourcing capabilities.

Total raised

$350M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2023